How Mohs surgeons utilize prognostic testing for high-risk cutaneous squamous cell carcinoma (SCC): a clinical impact study

Main Article Content

Sarah T Arron
Peninsula Dermatology

Alison L Fitzgerald
Castle Biosciences

Jennifer J Siegel
Castle Biosciences

Anesh Prasai
Castle Biosciences

Briana B Rackley
Castle Biosciences

Sarah J Kurley
Castle Biosciences

Brent Moody
Skin Cancer Surgery Center

Keywords

cutaneous squamous cell carcinoma, Mohs, surgery, prognosis

References

1. Rogers et al. JAMA Derm. 2015

2. skincancer.org, Skin Cancer Foundation

3. Schmults et al. JAMA Derm 2013

4. Wysong, et al. J Am Acad Dermatol. 2021

5. Ibrahim, et al. Future Oncol. 2021

6. Teplitz, et al. J Drugs Dermatol. 2019

7. Litchman, et al. CMRO. 2020

8. Arron, et al. J Drugs Dermatol. 2022

9. Hooper, et al. Cancer Invest. 2022

Article Sidebar

Poster PDF
Published
Nov 16, 2022
DOI https://doi.org/10.25251/skin.6.supp.100

Article Details

How to Cite
[1]
Arron, S.T., Fitzgerald, A.L., Siegel, J.J., Prasai, A., Rackley, B.B., Kurley, S.J. and Moody, B. 2022. How Mohs surgeons utilize prognostic testing for high-risk cutaneous squamous cell carcinoma (SCC): a clinical impact study. SKIN The Journal of Cutaneous Medicine. 6, 6 (Nov. 2022), s100. DOI:https://doi.org/10.25251/skin.6.supp.100.
Issue
Vol. 6 No. 6 (2022): November Issue & Poster Presentations from FC22 Dermatology Conference®
Section
Skin Cancer
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.

Most read articles by the same author(s)

1 2 > >>